Intranasal peptide delivery research provides essential methodological context for understanding how Semax is used in research settings. Intranasal administration is one of the more common delivery routes for Semax in animal research models, offering several advantages over peripheral administration routes for peptides that target the central nervous system. As the delivery method component of the Semax research cluster, this article reviews the published literature on intranasal peptide delivery in research settings, with a focus on how this approach is applied to Semax studies.
Intranasal Peptide Delivery: How Semax Is Studied in Research Settings
Semax · Published April 9, 2026 · Updated May 18, 2026 · 8 min read
Quick Answer
Intranasal peptide delivery research covers Semax administration methodology, pharmacokinetics, and central nervous system access in rodent models. Studies examine nasal-to-brain transport, CNS bioavailability, and intranasal dosing protocols that bypass blood-brain barrier limitations for neuropeptide research. For research use only, not for human consumption.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
- Intranasal Delivery for Central Nervous System Research
- Why Intranasal Delivery for Semax?
- Intranasal Delivery Methodology in Research
- Pharmacokinetics of Intranasal Semax
- Comparison With Other Delivery Routes
- Intranasal Delivery in the Broader Peptide Research Landscape
- Open Research Questions
- Conclusion
- Related Research Articles
- Explore Related Products
- Frequently Asked Questions
- Glossary
Frequently Asked Questions
What is Semax in research contexts?
+
Semax is a synthetic heptapeptide derived from the ACTH(4-10) fragment with extended stability via a C-terminal Pro-Gly-Pro tail. It is studied in preclinical models for cognitive endpoints, BDNF and NGF expression, and neuroprotection in cerebral ischemia.
Why is intranasal delivery used for Semax research?
+
Intranasal delivery allows Semax to bypass first-pass hepatic metabolism, achieve rapid CNS access via olfactory and trigeminal pathways, and avoid the gastrointestinal degradation that limits oral peptide bioavailability, supporting Semax's central nervous system pharmacology research.
How is intranasal delivery characterized in Semax research?
+
Pharmacokinetic studies measure plasma and brain Semax concentrations, autoradiography of labeled peptide distribution in the olfactory bulb and CNS, and behavioral or molecular markers of central effects timed against peptide delivery to confirm efficient CNS access.
Is Semax approved for human use?
+
Glossary
Key terms used in this article.
- ACTH(4-10)
- The 4-10 amino acid fragment of adrenocorticotropic hormone, the natural sequence from which Semax is derived.
- BDNF
- Brain-derived neurotrophic factor, a key neurotrophin supporting neuronal survival, synaptic plasticity, and learning.
- NGF
- Nerve growth factor, the prototypical neurotrophin essential for peripheral and central neuronal survival and growth.
- Intranasal Delivery
- Administration through the nasal mucosa, used for peptides like Semax to bypass first-pass metabolism and access the CNS.
- Heptapeptide
- A peptide consisting of seven amino acid residues; Semax has the sequence Met-Glu-His-Phe-Pro-Gly-Pro.
- Olfactory Pathway
- The neural route from nasal olfactory epithelium to the olfactory bulb, providing direct access from the nose to the CNS for some peptides.
More from the Blog
Continue exploring research insights and updates.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
